Page last updated: 2024-08-26

4-hydroxycyclophosphamide and Glioblastoma with Sarcomatous Component

4-hydroxycyclophosphamide has been researched along with Glioblastoma with Sarcomatous Component in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blute, T; Chen, CS; Ma, J; Waxman, DJ	1

Other Studies

1 other study(ies) available for 4-hydroxycyclophosphamide and Glioblastoma with Sarcomatous Component

Article	Year
Antiangiogenesis enhances intratumoral drug retention. Cancer research, 2011, Apr-01, Volume: 71, Issue:7 Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cell Line, Tumor; Cyclophosphamide; Drug Synergism; Gliosarcoma; Imidazoles; Indazoles; Male; Mice; Mice, Inbred ICR; Mice, SCID; Neovascularization, Pathologic; Random Allocation; Rats; Receptors, Vascular Endothelial Growth Factor; Transplantation, Heterologous	2011

Article

Year

Antiangiogenesis enhances intratumoral drug retention.

Cancer research, 2011, Apr-01, Volume: 71, Issue:7

Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cell Line, Tumor; Cyclophosphamide; Drug Synergism; Gliosarcoma; Imidazoles; Indazoles; Male; Mice; Mice, Inbred ICR; Mice, SCID; Neovascularization, Pathologic; Random Allocation; Rats; Receptors, Vascular Endothelial Growth Factor; Transplantation, Heterologous

2011